Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-12-27

Clinical Trial Update: Interest of Intravitreal Corticotherapy as the First-line Treatment for Post-operative Endophthalmitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating intravitreal corticotherapy as first-line treatment for post-operative endophthalmitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • intravitreal corticotherapy

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Post-operative Endophthalmitis | Phase 3 | Status: COMPLETED